The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Open accessAbstract
Although circulating DNA (ctDNA) could be an attractive tool for early cancer detection, diagnosis, prognosis, monitoring or prediction of response to therapies, knowledge on its origin, form and rate of release is poor and often contradictory. Here, we describe an experimental system to systematically examine these aspects. Nude mice were xenografted with human HT29 or SW620 colorectal carcinoma (CRC) cells and ctDNA was analyzed by Q-PCR with highly specific and sensitive primer sets at different times post-graft. We could discriminate ctDNA from normal (murine) cells and from mutated and non-mutated tumor (human) cells by using species-specific KRAS or PSAT1 primers and by assessing the presence of the BRAF V600E mutation. The concentration of human (mutated and non-mutated) ctDNA increased significantly with tumor growth. Conversely, and differently from previous studies, low, constant level of mouse ctDNA was observed, thus facilitating the study of mutated and non-mutated tumor derived ctDNA. Finally, analysis of ctDNA fragmentation confirmed the predominance of low-size fragments among tumor ctDNA from mice with bigger tumors. Higher ctDNA fragmentation was also observed in plasma samples from three metastatic CRC patients in comparison to healthy individuals. Our data confirm the predominance of mononucleosome-derived fragments in plasma from xenografted animals and, as a consequence, of apoptosis as a source of ctDNA, in particular for tumor-derived ctDNA. Altogether, our results suggest that ctDNA features vary during CRC tumor development and our experimental system might be a useful tool to follow such variations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
(1977) · PubMed · Cited by 1,801
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591 · cited 2×
“Ultimately this animal model might be useful for developing accurate and sensitive diagnostic tests for SNPs detection which are required for predicting the response to new potent anti-cancer compounds (25,26) and to determine whether ctDNA has any function or pathological effects (37,54,55).”
BackgroundMethodLièvre, A., Bachet, J.-B., Boige, V., Cayre, A., Le Corre, D., Buc, E., Ychou, M., Bouché, O., Landi, B., Louvet, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5906 · Cited by 1,444
Self-citationNuclear Acids In Human Blood Plasma.
Mandel, P., & Métais, P. (1948) · PubMed · Cited by 1,196
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L., & Quake, S. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808319105 · Cited by 1,114
Sawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
Nagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 733
Size Distributions of Maternal and Fetal DNA in Maternal Plasma
Chan, K. C. A., Zhang, J., Hui, A. B. Y., Wong, N., Lau, T. K., Leung, T. N., Lo, K.-W., Huang, D. W. S., & Lo, Y. M. D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024893 · Cited by 584
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440
Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387
Isolation and characterization of DNA from the plasma of cancer patients
Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90266-5 · Cited by 373 · cited 1×
“Circulating DNA (ctDNA) was first found in plasma samples by Mandel and Metais (1) and, only many years later, Stroun and coworkers determined that ctDNA in cancer patients’ plasma originated from tumor cells (2).”
BackgroundNg, S.-Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., & Kedes, L. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2720-2732.1985 · Cited by 372
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
Umetani, N., Giuliano, A. E., Hiramatsu, S. H., Amersi, F., Nakagawa, T., Martino, S., & Hoon, D. S. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9493 · Cited by 351
Translating insights from the cancer genome into clinical practice
Chin, L., & Gray, J. W. (2008) · Nature · doi:10.1038/nature06914 · Cited by 300
Fournié, G. J., Courtin, J.-P., Laval, F., Chalé, J.-J., Pourrat, J. P., Pujazon, M.-C., Lauque, D., & Carles, P. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03742-f · Cited by 268
García-Olmo, D. C., Domínguez, C., García-Arranz, M., Anker, P., Stroun, M., García-Verdugo, J. M., & García-Olmo, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3513 · Cited by 267
Su, Y.-H., Wang, M., Brenner, D. E., Ng, A., Melkonyan, H., Umansky, S., Syngal, S., & Block, T. M. (2004) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60497-7 · Cited by 238
Ng, S. Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., & Kedes, L. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2720 · Cited by 209
Vié, N., Copois, V., Bascoul-Mollevi, C., Denis, V., Bec, N., Robert, B., Fraslon, C., Conseiller, E., Molina, F., Larroque, C., et al. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-14 · Cited by 200
Self-citationDetection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
Schwarzenbach, H., Stoehlmacher, J., Pantel, K., & Goekkurt, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.025 · Cited by 193
Characterization of circulating DNA in healthy human plasma
Suzuki, N., Kamataki, A., Yamaki, J., & Homma, Y. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.09.001 · Cited by 179
Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors
Khanna, M., Park, P., Zirvi, M., Cao, W., Picon, A., Day, J., Paty, P., & Barany, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202291 · Cited by 168
Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA
Rago, C., Huso, D. L., Diehl, F., Karim, B., Liu, G., Papadopoulos, N., Samuels, Y., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0605 · Cited by 162
Clinical Relevance of Circulating Nucleosomes in Cancer
Holdenrieder, S., Nagel, D., Schalhorn, A., Heinemann, V., Wilkowski, R., von Pawel, J., Raith, H., Feldmann, K., Kremer, A. E., Müller, S., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.012 · Cited by 148
Frattini, M., Gallino, G., Signoroni, S., Balestra, D., Lusa, L., Battaglia, L., Sozzi, G., Bertario, L., Leo, E., Pilotti, S., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.021 · Cited by 138
Mouse Models of Colorectal Cancer and Liver Metastases
Heijstek, M. W., Kranenburg, O., & Rinkes, I. H. M. B. (2005) · Digestive Surgery · doi:10.1159/000085342 · Cited by 123
Overview of Circulating Nucleic Acids in Plasma/Serum
Butt, A. N., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.002 · Cited by 121
Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method
Morlan, J., Baker, J. B., & Sinicropi, D. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004584 · Cited by 115
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
Ellinger, J., Wittkamp, V., Albers, P., Perabo, F., Mueller, S. C., von Ruecker, A., & Bastian, P. J. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.118 · Cited by 108
Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer
Ruth E. Board, Williams, V. S., Knight, L., Shaw, J., Greystoke, A., Ranson, M., Dive, C., Blackhall, F. H., & Hughes, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.020 · Cited by 106
Cherepanova, A. V., TAMKOVICH, S. N., Bryzgunova, O. E., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.016 · Cited by 101
Profile of the Circulating DNA in Apparently Healthy Individuals
Beck, J., Urnovitz, H. B., Riggert, J., Clerici, M., & Schütz, E. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113597 · Cited by 100
Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E
Jarry, A., Masson, D., Cassagnau, E., Parois, S., LABOISSE, C. L., & Denis, M. G. (2004) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2004.05.004 · Cited by 97
Amount of DNA in plasma and cancer risk: A prospective study
Gormally, E., Hainaut, P. L., Caboux, É., Airoldi, L., Autrup, H. N., MALAVEILLE, C., Dunning, A. M., GARTE, S. J., Matullo, G., Overvad, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20327 · Cited by 93
Ma, T., Swinkels, D. W., Tj, R., et al. (2002) · PubMed · Cited by 90
Ellinger, J., Bastian, P. J., Ellinger, N., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.038 · Cited by 70
Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
Deligezer, U., Erten, N., Akişık, E. E., & Dalay, N. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.05.001 · Cited by 52
Preferential Isolation of Fragmented DNA Enhances the Detection of Circulating Mutated k-ras DNA
Wang, M., Block, T. M., Steel, L., Brenner, D. E., & Su, Y. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026914 · Cited by 51
Thijssen, M. A. O., Swinkels, D. W., Ruers, T. J. M., & Kok, J. B. D. (2001) · Radboud Repository (Radboud University) · Cited by 47
Integrity of Cell‐Free Plasma DNA in Patients with Lung Cancer and Nonmalignant Lung Disease
Schmidt, B., Weickmann, S., Witt, C. C., & Fleischhacker, M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.034 · Cited by 46
Gongora, C., Candeil, L., Vezzio, N., Copois, V., Denis, V., Bareil, C., Molina, F., Fraslon, C., Fraslon, C., Conseiller, E., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5838 · Cited by 40
Self-citationDNA of free and complexed origin in human plasma: Concentration and length distribution
Dennin, R. H. (1979) · Journal of Molecular Medicine · doi:10.1007/bf01477498 · Cited by 34
Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats
Garcı́a-Olmo, D. C., Gutiérrez-González, L., Ruiz-Piqueras, R., Picazo, M. G., & García‐Olmo, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.043 · Cited by 32
Circulating Nucleic Acids in Plasma/Serum and Tumor Progression
Samos, J., Garcı́a-Olmo, D. C., Picazo, M. G., Rubio-Vitaller, A., & García‐Olmo, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.022 · Cited by 30
Guadalajara, H., Domínguez–Berzosa, C., García‐Arranz, M., Herreros, M. D., Pascual, I., Baro, R. S., Garcı́a-Olmo, D. C., & García‐Olmo, D. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.01.002 · Cited by 24
Gahan, P. B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.003 · Cited by 19
Profile of Proteins Complexed with Circulating DNA of a Lung Cancer Patient
Kawamura, M. T., Paschoal, M. E. M., & Carvalho, M. D. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06590.x · Cited by 3
Cited by
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Self-citationLiquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Self-citationCirculating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Hodgkinson, C. L., Morrow, C. J., Li, Y., Metcalf, R. L., Rothwell, D. G., Trapani, F., Polanski, R., Burt, D. J., Simpson, K. L., Morris, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3600 · Cited by 694
Metadata
- Authors
- Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-21
- Volume
- 38
- Issue
- 18
- Pages
- 6159-6175
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1989498651
- Cited by
- 299
- References
- 54
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.